CN1835972A - B细胞疾病的联合治疗 - Google Patents

B细胞疾病的联合治疗 Download PDF

Info

Publication number
CN1835972A
CN1835972A CNA2004800222478A CN200480022247A CN1835972A CN 1835972 A CN1835972 A CN 1835972A CN A2004800222478 A CNA2004800222478 A CN A2004800222478A CN 200480022247 A CN200480022247 A CN 200480022247A CN 1835972 A CN1835972 A CN 1835972A
Authority
CN
China
Prior art keywords
antibody
cell
blys
seq
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800222478A
Other languages
English (en)
Chinese (zh)
Inventor
安德鲁·钱
龚谦
弗莱维厄斯·马丁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CN1835972A publication Critical patent/CN1835972A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CNA2004800222478A 2003-06-05 2004-06-04 B细胞疾病的联合治疗 Pending CN1835972A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47648103P 2003-06-05 2003-06-05
US60/476,414 2003-06-05
US60/476,481 2003-06-05
US60/476,531 2003-06-06

Publications (1)

Publication Number Publication Date
CN1835972A true CN1835972A (zh) 2006-09-20

Family

ID=37003283

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800222478A Pending CN1835972A (zh) 2003-06-05 2004-06-04 B细胞疾病的联合治疗

Country Status (3)

Country Link
CN (1) CN1835972A (sl)
DK (1) DK2272868T3 (sl)
SI (2) SI2272868T1 (sl)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011147320A1 (zh) * 2010-05-26 2011-12-01 四川大学 B细胞激活因子拮抗剂及其制备方法与用途
CN103502472A (zh) * 2011-02-28 2014-01-08 弗·哈夫曼-拉罗切有限公司 生物标记物和用于预测对b-细胞拮抗剂的响应的方法
CN103936833A (zh) * 2014-04-18 2014-07-23 天津大学 BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白
CN105999293A (zh) * 2011-04-01 2016-10-12 伊缪诺金公司 Cd37结合分子及其免疫缀合物
CN113136365A (zh) * 2021-04-29 2021-07-20 中山大学附属口腔医院 基于组蛋白去乙酰化酶抑制活性诱导调节性b细胞高效扩增的试剂及其应用

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011147320A1 (zh) * 2010-05-26 2011-12-01 四川大学 B细胞激活因子拮抗剂及其制备方法与用途
US9290582B2 (en) 2010-05-26 2016-03-22 Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. B cell activating factor antagonist and preparation method and use thereof
CN103502472A (zh) * 2011-02-28 2014-01-08 弗·哈夫曼-拉罗切有限公司 生物标记物和用于预测对b-细胞拮抗剂的响应的方法
CN103502472B (zh) * 2011-02-28 2017-06-06 弗·哈夫曼-拉罗切有限公司 生物标记物和用于预测对b‑细胞拮抗剂的响应的方法
CN105999293A (zh) * 2011-04-01 2016-10-12 伊缪诺金公司 Cd37结合分子及其免疫缀合物
CN105999293B (zh) * 2011-04-01 2019-07-23 德彪发姆国际有限公司 Cd37结合分子及其免疫缀合物
CN103936833A (zh) * 2014-04-18 2014-07-23 天津大学 BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白
CN113136365A (zh) * 2021-04-29 2021-07-20 中山大学附属口腔医院 基于组蛋白去乙酰化酶抑制活性诱导调节性b细胞高效扩增的试剂及其应用

Also Published As

Publication number Publication date
SI1631313T1 (sl) 2015-06-30
SI2272868T1 (sl) 2015-07-31
DK2272868T3 (en) 2015-06-15

Similar Documents

Publication Publication Date Title
CN1211123C (zh) 抗白细胞粘附分子vla－4的人源化抗体
EP1631313B1 (en) Combination therapy for b cell disorders
CN1993143A (zh) 用于治疗多发性硬化的方法
CN1446104A (zh) 利用b细胞排除抗体和免疫调制抗体联合治疗b细胞恶性肿瘤的相关应用
CN1802176A (zh) 治疗对tnf－alpha抑制剂应答不充分的患者中的自身免疫病
CN1441677A (zh) 抗细胞因子抗体或拮抗剂与抗－cd20在b细胞淋巴瘤治疗中的联合应用
CN1592645A (zh) 使用b细胞耗尽/免疫调节抗体组合治疗自身免疫病的联合疗法
CN101052654A (zh) 具有改变的效应子功能的多肽变体
CN1568198A (zh) 免疫调节抗体在治疗肿瘤性疾病中的用途
JP5960756B2 (ja) 自己免疫疾患の治療のためのＢＬｙＳ阻害剤および抗ＣＤ２０剤の組合せ
CN1378459A (zh) 使用与b细胞表面标志结合的拮抗剂治疗自身免疫病
CN1905897A (zh) 拮抗性抗－cd40单克隆抗体和它们的使用方法
CN1889978A (zh) 干扰素α抗体及其用途
CN1901937A (zh) 使用拮抗性抗－cd40单克隆抗体治疗多发性骨髓瘤
CN101056655A (zh) 治疗cd30阳性淋巴瘤的方法
CN1929862A (zh) 拮抗性抗－cd40单克隆抗体治疗慢性淋巴细胞性白血病的应用
CN1373672A (zh) 应用结合cd20的拮抗剂阻断对外来抗原的免疫应答
CN1599754A (zh) 抗trail－r抗体
CN1464908A (zh) 多价抗体及其应用
CN1662557A (zh) 抗cd20抗体及其融合蛋白和使用方法
CN101048428A (zh) 利用死亡受体配体和cd20抗体的方法
CN1646161A (zh) 自身免疫疾病的药剂和治疗方法
CN1860367A (zh) 人抗cd20抗体的测定法及其用途
CN1747969A (zh) 免疫球蛋白变体及其用途
CN1527723A (zh) 用cd2-结合剂治疗或预防皮肤病症的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1096695

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20060920

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1096695

Country of ref document: HK